Author： Chow Dorothy KL Leong Rupert WL
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.6, Iss.5, 2007-09, pp. : 479-485
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Mesalazine for the treatment of inflammatory bowel disease
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. :
Access to resources
Recommend
Thiopurine Treatment in Inflammatory Bowel Disease
Clinical Pharmacokinetics, Vol. 46, Iss. 9, 2007-01 ,pp. :
Ciclosporin/tacrolimus: Inflammatory bowel disease: 5 case reports
Reactions Weekly, Vol. 1, Iss. 1123, 2006-01 ,pp. :
Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease
Clinical Pharmacokinetics, Vol. 40, Iss. 10, 2001-01 ,pp. :
Treatment of Inflammatory Bowel Disease in the Elderly: An Update
By Pardi D.S. Loftus Jr E.V. Camilleri M.
Drugs & Aging, Vol. 19, Iss. 5, 2002-05 ,pp. :